{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:49:07Z","timestamp":1782182947069,"version":"3.54.5"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1987,1,1]],"date-time":"1987-01-01T00:00:00Z","timestamp":536457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:00:00Z","timestamp":1570060800000},"content-version":"vor","delay-in-days":11963,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Pharmacology"],"published-print":{"date-parts":[[1987]]},"DOI":"10.1016\/s0021-5198(19)43564-6","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T04:48:21Z","timestamp":1605674901000},"page":"81-90","source":"Crossref","is-referenced-by-count":45,"title":["Antithrombotic Effect of TRK-100, a Novel, Stable PGI2 Analogue"],"prefix":"10.1016","volume":"43","author":[{"given":"Teruhiko","family":"UMETSU","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"MURATA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshie","family":"TANAKA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eizaburo","family":"OSADA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"NISHIO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0021-5198(19)43564-6_bib1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0090-6980(80)80010-4","article-title":"Carbacyclin-a potent stable prostacyclin analogue for the inhibition of platelet aggregation","volume":"16","author":"Whittle","year":"1980","journal-title":"Prostaglandins"},{"key":"10.1016\/S0021-5198(19)43564-6_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/BF00505658","article-title":"The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK36374)-Equi-potent to PG12 in vitro","volume":"316","author":"Shror","year":"1981","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/S0021-5198(19)43564-6_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0262-1746(82)80018-8","article-title":"Inhibition of platelet aggregation and reversal of vasopressin-induced ECG changes by a carboprostacyclin analogue, ONO41483, in primates","volume":"9","author":"Adaikan","year":"1982","journal-title":"Prostaglandins Leuko-trienes Med."},{"key":"10.1016\/S0021-5198(19)43564-6_bib4","first-page":"547","article-title":"The cardiovascular and platelet actions of 9B-methyl carbacyclin (ciprostene), a chemically stable analogue of prostacyclin, in the dog and monkey. Br","volume":"85","author":"Allan","year":"1985","journal-title":"J. Pharmacol."},{"key":"10.1016\/S0021-5198(19)43564-6_bib5","first-page":"279","article-title":"Stereoselective synthesis of 5,6,7-trinor-4,8-inter-m-phenylene-PGI2 derivatives and their inhibitory activities to human platelet aggregation","volume":"15","author":"Ohno","year":"1985","journal-title":"Adv. Prostaglandin Thromboxane Leukotriene Res."},{"key":"10.1016\/S0021-5198(19)43564-6_bib6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0021-5198(19)63939-9","article-title":"Anti-platelet effects of a new PGI2 analog, TRK-100","volume":"39","author":"Nishio","year":"1985","journal-title":"Japan. J. Pharmacol."},{"key":"10.1016\/S0021-5198(19)43564-6_bib7","first-page":"1816","article-title":"The effect of a stable prostacyclin analogue on platelet function and experimentally-induced thrombosis in the microcirculation","volume":"35","author":"Sim","year":"1985","journal-title":"Arzneimittelforsch"},{"key":"10.1016\/S0021-5198(19)43564-6_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0038-1646657","article-title":"Effect of 1-methyl-2-mercapto-5-(3-pyridy I)-imidazole (KC-6141), an anti-aggregating compound, on experimental thrombosis in rats","volume":"39","author":"Umetsu","year":"1978","journal-title":"Thromb. Haemost."},{"key":"10.1016\/S0021-5198(19)43564-6_bib9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-0038-1646666","article-title":"Effect of 1-methyl-2-mercapto-5-(3-pyridyl)-imidazole on rabbit platelet aggregation in vitro and rat platelet retention","volume":"39","author":"Umetsu","year":"1978","journal-title":"Thromb. Haemost."},{"key":"10.1016\/S0021-5198(19)43564-6_bib10","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/263663a0","article-title":"An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation","volume":"263","author":"Moneada","year":"1976","journal-title":"Nature"},{"key":"10.1016\/S0021-5198(19)43564-6_bib11","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1055\/s-0038-1646792","article-title":"Mode of action of ticlopidine in inhibition of platelet aggregation in the rat","volume":"41","author":"Ashida","year":"1979","journal-title":"Thromb. Haemost."},{"key":"10.1016\/S0021-5198(19)43564-6_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0049-3848(72)90020-5","article-title":"Collagen-induced pulmonary thromboembolism in mice","volume":"1","author":"Nishizawa","year":"1972","journal-title":"Thromb. Res."},{"key":"10.1016\/S0021-5198(19)43564-6_bib13","first-page":"389","article-title":"Systemic effect of intravenous collagen-induced platelet aggregation and their modification by aspirin and pyridinocarbamate","volume":"60","author":"Kobayashi","year":"1974","journal-title":"Thromb. Diath. Haemorrh."},{"key":"10.1016\/S0021-5198(19)43564-6_bib14","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0090-6980(76)90125-8","article-title":"Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation","volume":"12","author":"Bunting","year":"1976","journal-title":"Prostaglandins"},{"key":"10.1016\/S0021-5198(19)43564-6_bib15","series-title":"Clinical Pharmacology of Prostacyclin","first-page":"181","article-title":"Cardiopulmonary bypass in man: effects of prostacyclin","author":"Bunting","year":"1981"},{"key":"10.1016\/S0021-5198(19)43564-6_bib16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(80)90661-3","article-title":"Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure","volume":"I","author":"Gimson","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/S0021-5198(19)43564-6_bib17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0002-9343(82)90409-0","article-title":"Prostacyclin substitutions for heparin in long term haemodialysis","volume":"73","author":"Smith","year":"1982","journal-title":"Am. J. Med."},{"key":"10.1016\/S0021-5198(19)43564-6_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0140-6736(83)91625-2","article-title":"Epoprostenol (prostacyclin) and severe arterial disease: A double-blind trial","volume":"I","author":"Belch","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/S0021-5198(19)43564-6_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-0038-1650182","article-title":"Successful treatment of Raynaud\u2019s syndrome with prostacyclin","volume":"45","author":"Belch","year":"1981","journal-title":"Thromb. Haemost."},{"key":"10.1016\/S0021-5198(19)43564-6_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(73)90233-X","article-title":"Femoralartery infusion of prostaglandin E1, in severe peripheral vascular disease","volume":"I","author":"Carlson","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/S0021-5198(19)43564-6_bib21","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0140-6736(76)90653-X","article-title":"Intravenous prostaglandin E1, in severe peripheral vascular disease","volume":"II","author":"Carlson","year":"1976","journal-title":"Lancet"}],"container-title":["Japanese Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819435646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021519819435646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T17:09:55Z","timestamp":1618420195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021519819435646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987]]},"references-count":21,"aliases":["10.1254\/jjp.43.81"],"journal-issue":{"issue":"1","published-print":{"date-parts":[[1987]]}},"alternative-id":["S0021519819435646"],"URL":"https:\/\/doi.org\/10.1016\/s0021-5198(19)43564-6","relation":{},"ISSN":["0021-5198"],"issn-type":[{"value":"0021-5198","type":"print"}],"subject":[],"published":{"date-parts":[[1987]]}}}